Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and devices for predicting anthracycline treatment efficacy

Methods and devices for predicting anthracycline treatment efficacy

US Patent 11214836 · Granted Jan 4, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer risk based on tumour clonality2025
Gene signature of residual risk following endocrine treatment in early breast ca2023
Gene signature of residual risk following endocrine treatment in early breast ca2023
Mitochondrial DNA prostate cancer marker and related systems and methods2022
Targeting the histone pathway to detect and overcome anthracyclin resistance2021
Targeting the histone pathway to detect and overcome anthracyclin resistance2021
Biopsy-driven genomic signature for prostate cancer prognosis2020
Materials and methods for prognosing lung cancer survival2011